BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Testicular cancer AND CEACAM5, CEA AND Diagnosis
20 results:

  • 1. Moderately differentiated Sertoli-Leydig cell tumor of ovary with associated mucinous carcinoma and carcinoid-A case report and review of literature.
    Ravichandaran A; Lakshmanan A; Kurian A; Prasad S
    Indian J Pathol Microbiol; 2021; 64(3):528-531. PubMed ID: 34341265
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. [testicular malignant Leydig cell tumor: A case report].
    Lu W; Zhang M; Wang SP; Wang X; Cai ZM
    Zhonghua Nan Ke Xue; 2016 May; 22(5):442-5. PubMed ID: 27416670
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. [Adenocarcinoma of the rete testis. A case report].
    Hagiuda J; Matsumoto M; Hanawa Y; Ishikawa H; Marumo K
    Nihon Hinyokika Gakkai Zasshi; 2010 Nov; 101(7):749-53. PubMed ID: 21174741
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Primary small cell carcinoma of the pleura: a case report with immunohistochemical and molecular genetic analyses of KIT and PDGFRA genes.
    Terada T
    Med Oncol; 2010 Dec; 27(4):1119-22. PubMed ID: 19859843
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Mucinous adenocarcinoma as heterologous element in intermediately differentiated Sertoli-Leydig cell tumor of the ovary.
    Virk R; Lu D
    Pathol Res Pract; 2010 Jul; 206(7):489-92. PubMed ID: 19674851
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. The immunohistochemical profile of malignant mesotheliomas of the tunica vaginalis: a study of 20 cases.
    Winstanley AM; Landon G; Berney D; Minhas S; Fisher C; Parkinson MC
    Am J Surg Pathol; 2006 Jan; 30(1):1-6. PubMed ID: 16330935
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Uterine retiform sertoli-leydig cell tumor: report of a case providing additional evidence that uterine tumors resembling ovarian sex cord tumors have a histologic and immunohistochemical phenotype of genuine sex cord tumors.
    Czernobilsky B; Mamet Y; David MB; Atlas I; Gitstein G; Lifschitz-Mercer B
    Int J Gynecol Pathol; 2005 Oct; 24(4):335-40. PubMed ID: 16175078
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Immunohistochemical study of testicular sex cord-stromal tumors, including staining with anti-inhibin antibody.
    McCluggage WG; Shanks JH; Whiteside C; Maxwell P; Banerjee SS; Biggart JD
    Am J Surg Pathol; 1998 May; 22(5):615-9. PubMed ID: 9591732
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. [A case of chronic scrotal hematocele].
    Aoki M; Ishikawa A; Ushiyama T; Suzuki K; Fujita K
    Hinyokika Kiyo; 1995 Oct; 41(10):817-9. PubMed ID: 8533682
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. [testicular mesothelioma. Report of a case].
    Loizaga A; Eguileor J; Arceo R; Ullate V; Unda M; Larrínaga JR; Flores N
    Actas Urol Esp; 1995; 19(7):573-6. PubMed ID: 8815671
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Utility of immunohistochemistry in distinguishing ovarian sertoli-stromal cell tumors from carcinosarcomas.
    Costa MJ; Morris RJ; Wilson R; Judd R
    Hum Pathol; 1992 Jul; 23(7):787-97. PubMed ID: 1612579
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Pulmonary nodules resembling bronchioloalveolar carcinoma in adolescent cancer patients.
    Travis WD; Linnoila RI; Horowitz M; Becker RL; Pass H; Ozols R; Gazdar A
    Mod Pathol; 1988 Sep; 1(5):372-7. PubMed ID: 2853363
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. [Significance of tumor markers in the treatment of urological malignancies].
    Akaza H; Kameyama S; Aso Y
    Gan To Kagaku Ryoho; 1987 Nov; 14(11):3034-40. PubMed ID: 2445294
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. [Tumor markers in testicular tumors].
    Jibiki K; Odagiri E; Demura R; Demura H; Yamaguchi Y
    Gan No Rinsho; 1985 Oct; 31(13):1709-16. PubMed ID: 3841165
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Tumor markers: value and limitations in the management of cancer patients.
    Bates SE; Longo DL
    Cancer Treat Rev; 1985 Sep; 12(3):163-207. PubMed ID: 2416441
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Overview of oncofetal antigens in cancer.
    Wepsic HT
    Ann Clin Lab Sci; 1983; 13(4):261-6. PubMed ID: 6194734
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Evaluation of five tumor markers (AFP, cea, hCG, hPL and SP1) in monitoring therapy and follow-up of patients with testicular germ cell tumors.
    Szymendera JJ; Zborzil J; Sikorowa L; Leńko J; Kamińska JA; Gadek A
    Oncology; 1983; 40(1):1-10. PubMed ID: 6185897
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Evaluation of PS beta 1G and other tumor markers in germ cell tumors of the testis.
    Blacker C; Feinstein MC; Roger M; Scholler R
    Andrologia; 1981; 13(5):458-67. PubMed ID: 6274232
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Value of five tumor markers (AFP, cea, hCG, hPL and SP1) in diagnosis and staging of testicular germ cell tumors.
    Szymendera JJ; Zborzil J; Sikorowa L; Kamińska JA; Gadek A
    Oncology; 1981; 38(4):222-9. PubMed ID: 6165945
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. [Value of carcinoembryonic antigen (cea) in the diagnosis of malignant tumors of the urogenital tract].
    Rost A; Kneppenberg U; Rost P
    Helv Chir Acta; 1976 Jul; 43(3):271-8. PubMed ID: 947865
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.